Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for st-segment elevation myocardial infarction (a harmonizing outcomes with revascularization and stents in acute myocardial infarction [HORIZONS-AMI] Substudy)

American Journal of Cardiology

Volumn 113, Issue 1, 2014, Pages 36-43

  Kirtane, Ajay J ^a,b   Sandhu, Prabhdeep ^a   Mehran, Roxana ^b,c   McEntegart, Margaret ^d   Cristea, Ecaterina ^e   Brener, Sorin J ^b,f   Xu, Ke ^b   Fahy, Martin ^b   Généreux, Philippe ^a,b   Wessler, Jeffrey D ^a   Stone, Gregg W ^a,b  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCOPROTEIN IIB INHIBITOR; GLYCOPROTEIN IIIA INHIBITOR; HEPARIN; HIRULOG; THIENOPYRIDINE DERIVATIVE; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING DISORDER; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CORE LABORATORY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INTRAPROCEDURAL THROMBOTIC EVENT; META ANALYSIS; MULTICENTER STUDY (TOPIC); PATIENT ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL PARAMETERS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT IMPLANTATION; STENT THROMBOSIS; THROMBECTOMY; THROMBUS; TREATMENT OUTCOME;

AGED; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84890429444     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.08.034     Document Type: Article

References (23)

1. G.W. Stone, C.L. Grines, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J.D. Carroll, B.D. Rutherford, A.J. Lansky Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
2. S.J. Brener Insights into the pathophysiology of ST-elevation myocardial infarction Am Heart J 151 2006 S4 S10
3. R.H. Mehta, K.J. Harjai, D. Cox, G.W. Stone, B. Brodie, J. Boura, W. O'Neill, C.L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) Investigators Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention J Am Coll Cardiol 42 2003 1739 1746
4. J.P. Henriques, F. Zijlstra, J.P. Ottervanger, M.J. de Boer, A.W. van't Hof, J.C. Hoorntje, and H. Suryapranata Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction Eur Heart J 23 2002 1112 1117
5. P. Fefer, A. Daoulah, B.H. Strauss, R. Chisholm, J.D. Sparkes, and A. Segev Visible angiographic complications predict short and long-term outcomes in patients with post-procedural creatine-phosphokinase elevation Catheter Cardiovasc Interv 76 2010 960 966
6. D. Brosh, A.R. Assali, A. Mager, A. Porter, D. Hasdai, I. Teplitsky, E. Rechavia, S. Fuchs, A. Battler, and R. Kornowski Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality Am J Cardiol 99 2007 442 445
7. M.L. Fokkema, P.J. Vlaar, T. Svilaas, M. Vogelzang, D. Amo, G.F. Diercks, A.J. Suurmeijer, and F. Zijlstra Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction Eur Heart J 30 2009 908 915
8. G. Ndrepepa, K. Tiroch, M. Fusaro, D. Keta, M. Seyfarth, R.A. Byrne, J. Pache, P. Alger, J. Mehilli, A. Schömig, and A. Kastrati 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction J Am Coll Cardiol 55 2010 2383 2389
9. K. Suenari, N. Shiode, K. Shirota, H. Ishii, K. Goto, A. Sairaku, S. Mikami, Y. Nakano, and K. Chayama Predictors and long-term prognostic implications of angiographic slow/no-flow during percutaneous coronary intervention for acute myocardial infarction Intern Med 47 2008 899 906
10. M.B. McEntegart, A.J. Kirtane, E. Cristea, S. Brener, R. Mehran, M. Fahy, J.W. Moses, and G.W. Stone Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 59 2012 1745 1751
11. Y.B. Pride, S. Mohanavelu, C. Zorkun, V. Kunadian, R.P. Giugliano, L.K. Newby, E. Braunwald, R.M. Califf, R.A. Harrington, C.M. Gibson EARLY ACS Investigators Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy JACC Cardiovasc Interv 5 2012 927 935
12. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
13. R. Mehran, B. Brodie, D.A. Cox, C.L. Grines, B. Rutherford, D.L. Bhatt, G. Dangas, F. Feit, E.M. Ohman, H. Parise, M. Fahy, A.J. Lansky, and G.W. Stone The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56
14. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, M. Möckel, A. Ochala, A. Kellock, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
15. C.M. Gibson, C.P. Cannon, W.L. Daley, J.T. Dodge Jr., B. Alexander Jr., S.J. Marble, C.H. McCabe, L. Raymond, T. Fortin, W.K. Poole, and E. Braunwald TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
16. G.W. Stone, M.A. Peterson, A.J. Lansky, G. Dangas, R. Mehran, and M.B. Leon Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J Am Coll Cardiol 39 2002 591 597
17. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
18. S.G. Ellis, M. Tendera, M.A. de Belder, A.J. van Boven, P. Widimsky, L. Janssens, H.R. Andersen, A. Betriu, S. Savonitto, J. Adamus, J.Z. Peruga, M. Kosmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobantu, L. Grinfeld, P. Armstrong, B.R. Brodie, H.C. Herrmann, G. Montalescot, F.J. Neumann, M.B. Effron, E.S. Barnathan, E.J. Topol FINESSE Investigators Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
19. E.C. Keeley, J.A. Boura, and C.L. Grines Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials Lancet 367 2006 579 588
20. T. Svilaas, P.J. Vlaar, I.C. van der Horst, G.F. Diercks, B.J. de Smet, A.F. van den Heuvel, R.L. Anthonio, G.A. Jessurun, E.S. Tan, A.J. Suurmeijer, and F. Zijlstra Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567
21. G. Sianos, M.I. Papafaklis, J. Daemen, S. Vaina, C.A. van Mieghem, R.T. van Domburg, L.K. Michalis, and P.W. Serruys Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden J Am Coll Cardiol 50 2007 573 583
22. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, PLATO Investigators, A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
23. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015